Examination of the effectiveness and complications of intrathecal pumps for giving opioids placed in patients with intractable cancer pain.

Examination of the effectiveness and complications of intrathecal pumps for giving opioids placed in patients with intractable cancer pain. - Examination of the effectiveness and complications of intrathecal pumps for giving opioids placed in patients with intractable cancer pain.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056535

Enrollment

Registered

2024-12-23

Start date

2025-01-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with intractable cancer pain

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who had a intrathecal pumps for giving opioids placed for intractable cancer pain at our hospital from January 2022 to December 2024.

Exclusion criteria

Exclusion criteria: Research subjects judged by the research director or attending physician to be unsuitable for safely conducting this research.

Design outcomes

Primary

Measure	Time frame
Improvement of pain and narcotic side effects after intrathecal pumps for giving opioids placement.	—

Countries

Japan

Contacts

Public ContactHiroki Mishima

Osaka Medical and Pharmaceutical University Department of Anesthesiology

hiroki.mishima@ompu.ac.jp072-683-1221

Outcome results